# TriRx Huntsville Pharmaceutical Services, LLC - Inspection Records

Source: https://www.keypedia.com/companies/trirx-huntsville-pharmaceutical-services-llc/bdf3220b-2a57-4125-b4ef-af4d1d9c9fa8

> Inspection records and compliance data for TriRx Huntsville Pharmaceutical Services, LLC in Huntsville, Alabama. Access full analysis and detailed observations.

---

## Details

- Name: TriRx Huntsville Pharmaceutical Services, LLC
- FEI Number: 3003197096
- City: Huntsville
- State: Alabama
- Country Name: United States
- Address Line 1: 120 Vintage Dr Ne
- Zip Code: 35811
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - TriRx Huntsville Pharmaceutical Services, LLC - 2026-06-15](https://www.keypedia.com/records/483/trirx-huntsville-pharmaceutical-services-llc/7a6bf5f2-b53b-4a78-93cc-181cad1da2a9) — source: FDA, date: June 15, 2026
- [FDA Inspection 1322326 - TriRx Huntsville Pharmaceutical Services, LLC - 2026-06-15](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/84548e82-46e0-4e70-b7ac-63ce50cfbc7f) — source: FDA, date: June 15, 2026
- [FDA Inspection 1216782 - TriRx Huntsville Pharmaceutical Services, LLC - 2023-08-11](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3b33daf8-bfa6-437e-9d8f-1611b733a98f) — classification: No Action Indicated (NAI), source: FDA, date: August 11, 2023
- [483 - TriRx Huntsville Pharmaceutical Services, LLC - 2022-04-01](https://www.keypedia.com/records/483/trirx-huntsville-pharmaceutical-services-llc/3cc0cfca-da41-428e-b501-67cd70f9d2ae) — source: FDA, date: April 1, 2022
- [FDA Inspection 1166895 - TriRx Huntsville Pharmaceutical Services, LLC - 2022-04-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3f8dc216-6d17-4b5b-a74a-14052c6e9579) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 1, 2022
- [FDA Inspection 978625 - TriRx Huntsville Pharmaceutical Services, LLC - 2016-04-21](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/89ab6faa-5411-4e35-966a-c29e63d3031b) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2016
- [483 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-12-19](https://www.keypedia.com/records/483/trirx-huntsville-pharmaceutical-services-llc/fcff31f5-6239-4b24-b66b-0b23a743cdd5) — source: FDA, date: December 19, 2014
- [FDA Inspection 908381 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-12-19](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/0fc0cd41-2f65-4177-ad00-19793dfbefed) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2014
- [FDA Inspection 891076 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-08-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/2d1caa8e-ca78-44d1-9156-75f72a2a356a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 1, 2014
- [FDA Inspection 888276 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-07-17](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/24d9ed6b-308e-463f-aa5d-65b1c35c9c70) — classification: No Action Indicated (NAI), source: FDA, date: July 17, 2014
- [FDA Inspection 833545 - TriRx Huntsville Pharmaceutical Services, LLC - 2013-05-30](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/9469a83d-564d-4d41-9ab1-b65086f1597b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2013
- [FDA Inspection 824161 - TriRx Huntsville Pharmaceutical Services, LLC - 2013-03-21](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/259d905f-1bb1-47fe-acfb-9235528ead4a) — classification: No Action Indicated (NAI), source: FDA, date: March 21, 2013
- [FDA Inspection 761267 - TriRx Huntsville Pharmaceutical Services, LLC - 2011-12-07](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/002658e5-2eb3-4d1e-a729-ce95f7db4e4d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2011

## Related Companies

- [Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.](https://www.keypedia.com/companies/istituto-biochimico-italiano-giovanni-lorenzini-spa/15ae51d8-a4ba-42a6-9100-2d04641f2514)
- [Hill Dermaceuticals, Inc.](https://www.keypedia.com/companies/hill-dermaceuticals-inc/f3bca28c-18cf-4743-8a40-705b02d4cc9c)
- [PureTek Corporation](https://www.keypedia.com/companies/puretek-corporation/428846ad-3d0d-4e9e-9b5e-41321940234c)
- [AML Riverside, LLC](https://www.keypedia.com/companies/aml-riverside-llc/1e839f8a-1cf4-48cd-90e1-62e3a2de0ca6)
- [Altasciences CDMO Philadelphia, LLC](https://www.keypedia.com/companies/altasciences-cdmo-philadelphia-llc/26bba634-aabd-494e-9c20-6a3b025a7403)
- [Accupac, Llc](https://www.keypedia.com/companies/accupac-llc/f9c2fbfc-4f22-433c-8e1c-bde11182952f)
- [Virbac Corporation](https://www.keypedia.com/companies/virbac-corporation/50f11944-6101-41cc-826d-abc0520ba802)
- [Norwich Pharmaceuticals, Inc.](https://www.keypedia.com/companies/norwich-pharmaceuticals-inc/24e5093f-2fde-40ab-a0a9-518fb46c4bfd)
- [Carnegie Pharmaceutical Llc](https://www.keypedia.com/companies/carnegie-pharmaceutical-llc/871b6bed-cfd1-4953-90e7-bfd439dc2050)
- [Eminent Services Corporation](https://www.keypedia.com/companies/eminent-services-corporation/0ca8cb23-54ac-4d36-b194-8c26e09ade69)

## Related Officers

- [Brandon C. Heitmeier](https://www.keypedia.com/people/brandon-c-heitmeier/09e1b64b-01de-4f8b-819a-1179d8b4c0c1)
- [Medical Officer at FDA](https://www.keypedia.com/people/brittny-c-cargo/a3479241-5390-4ddb-b892-df0bac1c89cf)
- [Investigator](https://www.keypedia.com/people/clinton-j-lott/ac4c7d18-13fd-4b1b-b2a1-06794c9960c7)
- [Jeffrey T. Prosterman](https://www.keypedia.com/people/jeffrey-t-prosterman/1343bea3-692d-484e-b29f-c9f8f052f09c)